Avttx
2 known investors
AVTTX is a clinical-stage company developing gene therapy treatments for retinal and ophthalmologic diseases. The company leverages adeno-associated virus (AAV) technology to address unmet medical needs in vision care.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
GM
George MontgomeryExecutive Chairman
<
<UNKNOWN>Chief Executive Officer and Founder